21546 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. phorphine derivatives, bilirubin, biliverdine
PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206
#2Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles
#3PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded
#4Compound containing a carbon or an oxygen isotope, preparation and use thereof, and composition comprising thereof
#5Porphyrazine optical and dual optical/MR contrast and therapeutic agents
#6PAA nanoparticles for enhancement of tumor imaging
#7RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors
#8Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis